Cite
HARVARD Citation
Grünwald, V. et al. (n.d.). 1605PDHealth-related quality of life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first line. Annals of oncology. p. . [Online].